The World Health Organisation (WHO) has praised India for its move to resume COVID-19 vaccine exports at a time when there is an acute shortage of vaccines, especially in lower-income countries.
WHO director-general Tedros Adhanom Ghebreyesus thanked India for resuming the export of COVID-19 vaccines in order to fulfil its commitment towards COVAX.
“Thank you Health Minister Mansukh Mandaviya for announcing India will resume crucial COVID-19 vaccine shipments to COVAX in October,” Ghebreyesus tweeted on Wednesday. The WHO director-general further said India’s decision to export COVID-19 vaccines “is an important development in support of reaching the 40 per cent vaccination target in all countries by the end of the year”.
India’s commitment towards COVAX
Earlier this week, Mansukh Mandaviya said that India will resume export and donation of COVID-19 vaccines under its ‘Vaccine Maitri’ initiative from October onwards.
Notably, the export of vaccines was stopped by the government in April after facing severe criticism over the shortage of vaccines in the country amid rising infections. By then, the Centre had already supplied over 66 million doses of COVID-19 vaccines to more than 84 countries as part of the Vaccine Maitri initiative.
While addressing the media, Mansukh Mandaviya had said that India will resume the export of coronavirus vaccines in order to fulfill its commitment towards COVAX. Surplus vaccines will be exported as per India’s commitment to the collective fight against COVID-19, the minister added.
He had said that more than 30 crore doses of COVID-19 vaccines will be produced in India in the month of October alone. Over 100 crore doses will be produced in the fourth quarter of this year, the minister added.
To read the latest news in Gujarati click here